Injectable GLP-1s: Nearly 100% bioavailability Consistent, predictable absorption Doses of 1-2.4mg weekly for semaglutide FDA-Approved Oral Tablets: 0.4-1% bioavailability Requires 7-25mg doses to achieve similar effects Must be taken with specific timing and fasting requirements Compounded ODT Formulations: Theoretical bioavailability advantage over swallowed tablets Sublingual/buccal delivery bypasses stomach acid and first-pass metabolism However, research on peptide delivery shows challenges: peptides may be degraded by salivary enzymes, have poor permeability due to large molecular size, and face continuous wash-away from saliva No clinical trials have established actual bioavailability or effectiveness for compounded GLP-1 ODTs These formulations are not FDA-approved and haven't undergone rigorous testing The theoretical advantage of ODT formulations is that by dissolving in the mouth rather than the stomach, they could achieve better absorption than swallowed tablets while maintaining the convenience of a daily, needle-free option
These insights reveal your genetic predisposition to GLP-1 response and help your provider choose the right medication and starting dose, reducing the likelihood and severity of fatigue
Discontinuation: If the rash is severe and does not improve with treatment, discontinuing semaglutide might be necessary
Our surgeons create individualised treatment plans with a profound awareness of anatomical and cosmetic details to produce exceptional outcomes that are customised just for you
For all these reasons and more, Ive added L-carnitine to my daily supplement regimen and suggest you consider doing the same
& Jaadane, I
